Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|38|4372-4378

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.38, 2011-12, pp. : 4372-4378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review

By  

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3661-3667

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin, Autophagy and Intestinal Bowel Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4816-4827

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By >   Pardi Darrell S.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite

Macrophages in Inflammatory Bowel Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite